Abstract
Cytolysis of leukemic cells by peripheral blood‐derived macrophages was examined by means of an in vitro111In release assay. Monocytes prepared on culture dishes lyse YK‐M2. However, when monocytes were cultured in vitro and transformed into macrophages, they lost most of their lytic activity. The addition of human recombinant interleukin‐2 (rIL‐2) on day 5 in culture enhanced the lytic activity significantly. Similarly, treatment of macrophages with human recombinant interferon gamma (rIFN‐γ) promoted the lysis of YK‐M2 and K‐562, although the extent of lysis was smaller than that by rIL‐2. Macrophages activated with rIL‐2 and rIFN‐γ also Iysed human leukemic cells. Activated macrophages lysed leukemic cells of acute myelocytic leukemia more than acute lymphocytic leukemia cells. Macrophages derived from the peripheral blood of patients with leukemia were examined for their lytic activity against YK‐M2. The patient's macrophages lysed more YK‐M2 than did control macrophages when they were activated with rIL‐2 and rIFN‐γ. The macrophages of two patients also demonstrated autologous leukemic cell lysis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
